RecruitingNCT07140757

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers


Sponsor

M.D. Anderson Cancer Center

Enrollment

50 participants

Start Date

Aug 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating how well radiofrequency ablation (RFA) — a minimally invasive procedure that uses heat to destroy abnormal tissue — works for treating benign (non-cancerous) thyroid nodules, indeterminate nodules, low-risk thyroid cancers, and locally recurrent thyroid cancer in patients who cannot have or prefer to avoid surgery. **You may be eligible if...** - You are over 18 years old - You have a thyroid nodule or low-risk thyroid cancer that has been confirmed by biopsy - Your nodule is causing symptoms (pressure in the neck, visible swelling) or you have a concerning nodule type - You are not a surgical candidate or have declined surgery **You may NOT be eligible if...** - Your thyroid cancer has spread to lymph nodes or distant organs - You have had prior neck radiation - You have a pacemaker or other implanted device incompatible with RFA - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07140757


Related Trials